Literature DB >> 24063572

Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization.

Jan Fiedler1, Andrea Stöhr, Shashi Kumar Gupta, Dorothee Hartmann, Angelika Holzmann, Annette Just, Arne Hansen, Denise Hilfiker-Kleiner, Thomas Eschenhagen, Thomas Thum.   

Abstract

UNLABELLED: Smooth muscle cells (SMCs) are key components within the vasculature. Dependent on the stimulus, SMC can either be in a proliferative (synthetic) or differentiated state. Alterations of SMC phenotype also appear in several disease settings, further contributing to disease progression. AIMS: Here, we asked whether microRNAs (miRNAs, miRs), which are strong posttranscriptional regulators of gene expression, could alter SMC proliferation. Results and Innovation: Employing a robotic-assisted high-throughput screening method using miRNA libraries, we identified hypoxia-regulated miR-24 as a master regulator of SMC proliferation. Proteome profiling showed a strong miR-24-dependent impact on cellular stress-associated factors, overall resulting in reduced stress resistance. In vitro, synthetic miR-24 overexpression had detrimental effects on SMC functional capacity inducing apoptosis, migration defects, enhanced autophagy, and loss of contractile marker genes. Impaired SMC function was mediated in part by the herein identified direct target gene heme oxygenase 1. Ex vivo, miR-24 was shown to inhibit the development of vasculature in a model of engineered heart tissue.
CONCLUSION: Collectively, we report the identification of the hypoxamir-24 as an inhibitor of SMC proliferation, contributing to loss of vascularization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24063572      PMCID: PMC4142777          DOI: 10.1089/ars.2013.5418

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  27 in total

1.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.

Authors:  W H Zimmermann; C Fink; D Kralisch; U Remmers; J Weil; T Eschenhagen
Journal:  Biotechnol Bioeng       Date:  2000-04-05       Impact factor: 4.530

2.  Changes in myosin distribution in dedifferentiating and redifferentiating smooth muscle cells in tissue culture.

Authors:  U Gröschel-Stewart; J H Chamley; G R Campbell; G Burnstock
Journal:  Cell Tissue Res       Date:  1975-12-29       Impact factor: 5.249

3.  Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media.

Authors:  P R Mosse; G R Campbell; Z L Wang; J H Campbell
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

4.  Functional screening identifies miRNAs inducing cardiac regeneration.

Authors:  Ana Eulalio; Miguel Mano; Matteo Dal Ferro; Lorena Zentilin; Gianfranco Sinagra; Serena Zacchigna; Mauro Giacca
Journal:  Nature       Date:  2012-12-05       Impact factor: 49.962

5.  Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes.

Authors:  K A Webster; D J Discher; N H Bishopric
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

6.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  Myocardin: a component of a molecular switch for smooth muscle differentiation.

Authors:  Jiyuan Chen; Chad M Kitchen; Jeffrey W Streb; Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

8.  Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.

Authors:  Amarnath Talasila; Haixiang Yu; Matthew Ackers-Johnson; Martine Bot; Theo van Berkel; Martin R Bennett; Ilze Bot; Sanjay Sinha
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-03       Impact factor: 8.311

9.  The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

Authors:  Ahmet Ucar; Shashi K Gupta; Jan Fiedler; Erdem Erikci; Michal Kardasinski; Sandor Batkai; Seema Dangwal; Regalla Kumarswamy; Claudia Bang; Angelika Holzmann; Janet Remke; Massimiliano Caprio; Claudia Jentzsch; Stefan Engelhardt; Sabine Geisendorf; Carolina Glas; Thomas G Hofmann; Michelle Nessling; Karsten Richter; Mario Schiffer; Lucie Carrier; L Christian Napp; Johann Bauersachs; Kamal Chowdhury; Thomas Thum
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  miRNA biogenesis enzyme Drosha is required for vascular smooth muscle cell survival.

Authors:  Pei Fan; Zixuan Chen; Peng Tian; Wen Liu; Yan Jiao; Yi Xue; Anindya Bhattacharya; Jianmin Wu; Meifen Lu; Yuqi Guo; Yan Cui; Weikuan Gu; Weiwang Gu; Junming Yue
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more
  21 in total

1.  MicroRNA-24 antagonism prevents renal ischemia reperfusion injury.

Authors:  Johan M Lorenzen; Tamas Kaucsar; Celina Schauerte; Roland Schmitt; Song Rong; Anika Hübner; Kristian Scherf; Jan Fiedler; Filippo Martino; Regalla Kumarswamy; Malte Kölling; Inga Sörensen; Hebke Hinz; Joerg Heineke; Eva van Rooij; Hermann Haller; Thomas Thum
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  MicroRNA-mediated interacting circuits predict hypoxia and inhibited osteogenesis of stem cells, and dysregulated angiogenesis are involved in osteonecrosis of the femoral head.

Authors:  Gour-Shenq Kao; Yuan-Kun Tu; Pei-Hsun Sung; Feng-Sheng Wang; Yu-Der Lu; Chen-Ta Wu; Rio L C Lin; Hon-Kan Yip; Mel S Lee
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

Review 3.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

4.  Role of miR-18a and miR-25 disruption and its mechanistic pattern in progression of liver cancer.

Authors:  Yijie Lu; Zhai Min; Ancheng Qin; Jianwu Wu; Xinwei Jiang; Zhiming Qiao
Journal:  3 Biotech       Date:  2020-01-28       Impact factor: 2.406

Review 5.  Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Transl Res       Date:  2015-06-23       Impact factor: 7.012

Review 6.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

7.  Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair.

Authors:  Farima Zahedi; Maliheh Nazari-Jahantigh; Zhe Zhou; Pallavi Subramanian; Yuanyuan Wei; Jochen Grommes; Stefan Offermanns; Sabine Steffens; Christian Weber; Andreas Schober
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

8.  Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue.

Authors:  Andrea Stoehr; Marc N Hirt; Arne Hansen; Moritz Seiffert; Lenard Conradi; June Uebeler; Florian P Limbourg; Thomas Eschenhagen
Journal:  Tissue Eng Part A       Date:  2016-02       Impact factor: 3.845

Review 9.  RNA-based diagnostic and therapeutic strategies for cardiovascular disease.

Authors:  Dongchao Lu; Thomas Thum
Journal:  Nat Rev Cardiol       Date:  2019-06-11       Impact factor: 32.419

10.  MicroRNA-24 Regulates Osteogenic Differentiation via Targeting T-Cell Factor-1.

Authors:  Weigong Zhao; Caijun Wu; Yanying Dong; Yunfeng Ma; Yaofeng Jin; Yanhong Ji
Journal:  Int J Mol Sci       Date:  2015-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.